Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01128166 · ClinicalTrials.gov registry record
Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 975
- Enrollment target
NCT01128166: Completed study, sponsored by Boston Scientific Corporation.
NCT01128166 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 975 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01128166 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 975 participants
- Enrollment target
Study Summary
The goal of the MultiSENSE study is to collect chronic information from multiple sensors in an implanted device for evaluation in heart failure patients.
Primary Outcome
The primary objectives of this study are to determine how ambulatory sensor measurements change with worsening heart failure, and to develop multisensor detection algorithms. Additional data will be collected to compare sensor measurements against reference measurements when the subject is hospitalized for HF. Data from this study may also be used for determining prospective endpoints and sample sizes for future studies. There are no formal statistical primary or secondary endpoints defined for
Interventions
- DEVICE COGNIS CRT-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 975 participants |
| Start Date | 2010-06 |
| Est. Completion | 2015-07 |
What the finished NCT01128166 record still lists
NCT01128166 is an observational study that tracks outcomes without assigning an intervention. The registered 975 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which COGNIS CRT-D is the first listed.
NCT01128166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01128166 about?
NCT01128166 is a clinical study titled "Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices". The goal of the MultiSENSE study is to collect chronic information from multiple sensors in an implanted device for evaluation in heart failure patients.
What is the current status of trial NCT01128166?
This trial is currently completed. The enrollment target is 975 participants. The study started on 2010-06. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01128166?
The interventions under investigation include: COGNIS CRT-D (DEVICE).
Who is sponsoring clinical trial NCT01128166?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05600777 · 975 participants · Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
- NCT06541704 · 975 participants · Phase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- NCT06820736 · 975 participants · NA
A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion
- NCT07216482 · 975 participants · Phase 3
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia